The 89th Edition HDA Factbook (2017-2018) provides comprehensive distribution performance metrics that highlight growth and trends in the pharmaceutical industry.

PRICE : $0.00 - $0.00

The 10th edition of the HDA Research Foundation’s annual benchmarking publication on specialty pharmaceuticals offers insight into this unique marketplace, and closely examines specialty distribution measures...

PRICE : $0.00 - $0.00

Since 1992, the 340B Drug Pricing Program has played a modest, but increasingly important, role in the U.S. healthcare market.

PRICE : $0.00 - $0.00

Product returns are inevitable. Annually, more than 120 million product units — exceeding $13 billion in value — move through the reverse distribution process.

PRICE : $0.00 - $0.00

This whitepaper provides an analysis of the current market for biosimilars in the U.S. through interviews conducted with senior executives from specialty pharmaceutical manufacturing and distribution companies.

PRICE : $0.00 - $0.00

This turnkey presentation for manufacturer, distributor and pharmacy presenters/trainers includes an explanation of the pharmaceutical supply chain players and a discussion on the economics of distribution.

PRICE : $0.00 - $0.00

This turnkey presentation includes an explanation of the specialty pharmaceutical supply chain players and a discussion on the economics of specialty pharmaceutical distribution.

PRICE : $0.00 - $0.00

Through interviews, survey work and secondary data, this publication provides an understanding of the role distributors play to ensure the efficient and effective distribution of specialty medications.

PRICE : $0.00 - $0.00

The information conveyed about new products has critical downstream implications that can affect the appropriate receiving, handling and storage at the distributor’s facility and farther along the healthcare...

This report summarizes the results of the pilot study conducted by HDA, working with Ernst & Young LLP (EY) and HDA’s Traceability Pilots Work Group.

PRICE : $0.00 - $0.00